SCHEMBL3770868

SCHEMBL3770868

CC=CCCCOc1cccc(CN)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.36
RPS6KA1 Q15418 1/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
HTR1B P28222 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2D6 P10635 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
HPGD P15428 3/20 0.32
ATM Q13315 2/20 0.32
CYP2C9 P11712 1/20 0.32
MAOB P27338 2/20 0.31
LTB4R Q15722 1/20 0.31
LTB4R2 Q9NPC1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766281 0.96 L3MBTL1 (0.36) L3MBTL1RPS6KA1MAPTTDP1HTR1B
SCHEMBL3770673 0.94 L3MBTL1 (0.35) L3MBTL1RPS6KA1MAPTTDP1HTR1B
SCHEMBL3764835 0.93 RPS6KA1 (0.35) L3MBTL1RPS6KA1MAPTNPSR1TDP1
SCHEMBL3766396 0.87 L3MBTL1 (0.39) L3MBTL1RPS6KA1MAPTNPSR1TDP1
SCHEMBL3771934 0.87 L3MBTL1 (0.39) L3MBTL1RPS6KA1MAPTNPSR1TDP1
SCHEMBL3764641 0.83 TAAR1 (0.39) L3MBTL1RPS6KA1MAPTTAAR1MAOB
SCHEMBL3770876 0.83 L3MBTL1 (0.38) L3MBTL1RPS6KA1MAPTNPSR1TDP1
SCHEMBL3764583 0.83 CYP1A2 (0.40) L3MBTL1MAPTCYP1A2CYP2C19KDM4E
SCHEMBL3765885 0.82 KDM4E (0.40) L3MBTL1RPS6KA1MAPTNPSR1HTR1B
SCHEMBL3766158 0.79 CYP1A2 (0.35) L3MBTL1RPS6KA1MAPTNPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 L3MBTL1 40/4885RPS6KA1 1556/4885MAPT 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.